home.social

#pharmabcine — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #pharmabcine, aggregated by home.social.

  1. Yonhap Infomax News @[email protected] ·

    PharmAbcine’s court bid to halt its KOSDAQ delisting was rejected, paving the way for final trading and removal from the market as the Korea Exchange resumes procedures.
    #YonhapInfomax #PharmAbcine #KOSDAQ #Delisting #KoreaExchange #CourtDecision #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #pharmabcine #kosdaq #delisting #koreaexchange #courtdecision
  2. Yonhap Infomax News @[email protected] ·

    PharmAbcine’s court bid to halt its KOSDAQ delisting was rejected, paving the way for final trading and removal from the market as the Korea Exchange resumes procedures.
    #YonhapInfomax #PharmAbcine #KOSDAQ #Delisting #KoreaExchange #CourtDecision #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #pharmabcine #kosdaq #delisting #koreaexchange #courtdecision
  3. Yonhap Infomax News @[email protected] ·

    PharmAbcine’s court bid to halt its KOSDAQ delisting was rejected, paving the way for final trading and removal from the market as the Korea Exchange resumes procedures.
    #YonhapInfomax #PharmAbcine #KOSDAQ #Delisting #KoreaExchange #CourtDecision #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #stockmarket #bonds #securities #banking #financialmarkets #economics
  4. Yonhap Infomax News @[email protected] ·

    PharmAbcine’s court bid to halt its KOSDAQ delisting was rejected, paving the way for final trading and removal from the market as the Korea Exchange resumes procedures.
    #YonhapInfomax #PharmAbcine #KOSDAQ #Delisting #KoreaExchange #CourtDecision #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #pharmabcine #kosdaq #delisting #koreaexchange #courtdecision
  5. Yonhap Infomax News @[email protected] ·

    PharmAbcine Inc., facing potential delisting, has invested KRW 10 billion ($7.6 million) to establish Symbance, aiming to enter the venture investment sector by securing a New Technology Business Finance Company license, though regulatory disclosure remains pending.
    #YonhapInfomax #PharmAbcine #Symbance #VentureInvestment #NTBFC #DisclosureObligation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #pharmabcine #symbance #ventureinvestment #ntbfc #disclosureobligation
  6. Yonhap Infomax News @[email protected] ·

    PharmAbcine Inc., facing potential delisting, has invested KRW 10 billion ($7.6 million) to establish Symbance, aiming to enter the venture investment sector by securing a New Technology Business Finance Company license, though regulatory disclosure remains pending.
    #YonhapInfomax #PharmAbcine #Symbance #VentureInvestment #NTBFC #DisclosureObligation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #pharmabcine #symbance #ventureinvestment #ntbfc #disclosureobligation
  7. Yonhap Infomax News @[email protected] ·

    PharmAbcine Inc., facing potential delisting, has invested KRW 10 billion ($7.6 million) to establish Symbance, aiming to enter the venture investment sector by securing a New Technology Business Finance Company license, though regulatory disclosure remains pending.
    #YonhapInfomax #PharmAbcine #Symbance #VentureInvestment #NTBFC #DisclosureObligation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #stockmarket #bonds #securities #banking #financialmarkets #economics
  8. Yonhap Infomax News @[email protected] ·

    PharmAbcine Inc., facing potential delisting, has invested KRW 10 billion ($7.6 million) to establish Symbance, aiming to enter the venture investment sector by securing a New Technology Business Finance Company license, though regulatory disclosure remains pending.
    #YonhapInfomax #PharmAbcine #Symbance #VentureInvestment #NTBFC #DisclosureObligation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #pharmabcine #symbance #ventureinvestment #ntbfc #disclosureobligation